GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnamed Holdings Corp (OTCPK:DGNMF) » Definitions » ROE % Adjusted to Book Value

DGNMF (Diagnamed Holdings) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Diagnamed Holdings ROE % Adjusted to Book Value?

Diagnamed Holdings's ROE % for the quarter that ended in Dec. 2024 was 0.00%. Diagnamed Holdings's PB Ratio for the quarter that ended in Dec. 2024 was N/A. Diagnamed Holdings's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.


Diagnamed Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for Diagnamed Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnamed Holdings ROE % Adjusted to Book Value Chart

Diagnamed Holdings Annual Data
Trend Sep21 Sep22 Sep23 Sep24
ROE % Adjusted to Book Value
- - -9.44 -

Diagnamed Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.25 -5.86 - - -

Competitive Comparison of Diagnamed Holdings's ROE % Adjusted to Book Value

For the Health Information Services subindustry, Diagnamed Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnamed Holdings's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnamed Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Diagnamed Holdings's ROE % Adjusted to Book Value falls into.



Diagnamed Holdings ROE % Adjusted to Book Value Calculation

Diagnamed Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Diagnamed Holdings's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diagnamed Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Diagnamed Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnamed Holdings Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.